focus
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: New Medicare drug pricing powers could soon be upended in court
Next article: New Medicare drug pricing powers could soon be upended in court
entertainment
focus
-
JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
2025-09-30 21:46 -
Warren pushes Witty on UnitedHealth's control over physicians
2025-09-30 21:04 -
Readout LOUD podcast: live from JPM 2024
2025-09-30 20:57 -
JPM 2024: Verve Therapeutics looks to mainstream genome editing
2025-09-30 20:50 -
Risky weight loss products often used by teens globally, per study
2025-09-30 20:48 -
Class action alleges UnitedHealth concealed DOJ probe
2025-09-30 20:30